Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria

Dean P Jones1, John J Lemasters, Derick Han

  • 1Dept of Medicine, Emory University, 4131 Rollins Research Center, Atlanta, GA 30322, USA.

Insights

Mitochondria are vital for cell life and death. Disrupting their function harms energy and lipid metabolism, triggering cell death, especially in drug-induced liver injury.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Toxicology

Background:

  • Mitochondria are central to cellular energy production and programmed cell death.
  • Mitochondrial dysfunction significantly impacts cellular metabolism, including energy and lipid pathways.
  • The role of mitochondria in drug-induced cell death is an area of growing research interest.

Purpose of the Study:

  • To review and assess the current understanding of mitochondria's role in drug-induced hepatotoxicity.
  • To highlight the mechanisms by which mitochondrial impairment contributes to liver injury from drugs.

Main Methods:

  • Literature review and synthesis of existing research on mitochondrial function and drug hepatotoxicity.
  • Analysis of studies investigating the impact of drug exposure on mitochondrial pathways.

Main Results:

  • Mitochondrial dysfunction is a key event in drug-induced liver injury, affecting ATP production and increasing oxidative stress.
  • Impaired lipid metabolism and the release of pro-apoptotic factors from mitochondria contribute to hepatocellular death.
  • Specific drug classes have been shown to target mitochondrial components, leading to toxicity.

Conclusions:

  • Mitochondria are critical targets in understanding and potentially mitigating drug-induced hepatotoxicity.
  • Further research into mitochondrial pathways offers therapeutic opportunities for liver protection against drug damage.

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...